안지오텐신 전환 효소(ACE) 억제제 시장 점유율 분석 및 기회 [2025-2031]
Angiotensin Converting Enzyme (ACE) Inhibitors Market Report Analysis
Angiotensin Converting Enzyme (ACE) Inhibitors Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Novartis AG
- Pfizer, Inc
- Merck & Co., Inc.
- Bristol Myers Squibb
- Astra and Zeneca
- UCB (Schwarz Pharma Inc.)
- Solvay Pharmaceuticals B.V.
- Abbott
- Endo International (Par Pharmaceutical, Inc.)
Regional Overview
- 북미
- 유럽
- 아시아 태평양
- 중남미
- 중동 및 아프리카
Market Segmentation
By 제품
- Benazepril
- Captopril
- Enalapril
- Fosinopril
- Lisinopril
- 기타
By 적응증
- 심혈관질환
- 고혈압
- 만성신장질환
- 당뇨병
- 피부경화증
- 편두통
By 유통 채널
- 온라인 약국
- 소매 및 병원 약국
By 지리
- 북미
- 유럽
- 아시아 태평양
- 중남미
Get Free Sample For